guest ::
| Home > Publications database > Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs). |
| Home > Publications database > Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs). |
| Book/Journal Article (Review Article) | DKFZ-2022-02466 |
;
2023
Springer
New York, NY
ISBN: 978-3-031-12389-4 (print), 978-3-031-12390-0 (electronic)
This record in other databases: 
Please use a persistent id in citations: doi: DOI: 10.1007/978-3-031-12390-0_12 doi:10.1007/978-3-031-12390-0_12 doi:DOI: 10.1007/978-3-031-12390-0_12
Abstract: Glycosphingolipids (GSLs) are a diverse group of membrane components occurring mainly on the surfaces of mammalian cells. They and their metabolites have a role in intercellular communication, serving as versatile biochemical signals (Kaltner et al, Biochem J 476(18):2623-2655, 2019) and in many cellular pathways. Anionic GSLs, the sialic acid containing gangliosides (GGs), are essential constituents of neuronal cell surfaces, whereas anionic sulfatides are key components of myelin and myelin forming oligodendrocytes. The stepwise biosynthetic pathways of GSLs occur at and lead along the membranes of organellar surfaces of the secretory pathway. After formation of the hydrophobic ceramide membrane anchor of GSLs at the ER, membrane-spanning glycosyltransferases (GTs) of the Golgi and Trans-Golgi network generate cell type-specific GSL patterns for cellular surfaces. GSLs of the cellular plasma membrane can reach intra-lysosomal, i.e. luminal, vesicles (ILVs) by endocytic pathways for degradation. Soluble glycoproteins, the glycosidases, lipid binding and transfer proteins and acid ceramidase are needed for the lysosomal catabolism of GSLs at ILV-membrane surfaces. Inherited mutations triggering a functional loss of glycosylated lysosomal hydrolases and lipid binding proteins involved in GSL degradation cause a primary lysosomal accumulation of their non-degradable GSL substrates in lysosomal storage diseases (LSDs). Lipid binding proteins, the SAPs, and the various lipids of the ILV-membranes regulate GSL catabolism, but also primary storage compounds such as sphingomyelin (SM), cholesterol (Chol.), or chondroitin sulfate can effectively inhibit catabolic lysosomal pathways of GSLs. This causes cascades of metabolic errors, accumulating secondary lysosomal GSL- and GG- storage that can trigger a complex pathology (Breiden and Sandhoff, Int J Mol Sci 21(7):2566, 2020).
Keyword(s): Alzheimer ; Catabolism ; Degradation ; Development ; Endosomal pathway ; Frontal lobe dementia ; Ganglio-series ; Ganglioside ; Genetic disease ; Glycolipid ; Glycosphingolipid ; Glycosyltransferase ; Hydrolase ; Intra-lysosomal luminal vesicle (ILV) ; Lysosomal storage disease (LSD) ; Lysosome ; Membrane-surface ; Metabolism ; Neurodegenerative disease ; Neuron ; Organelle ; Parkinson ; Receptor ; Secondary storage ; Secretory pathway ; Sphingolipid-binding protein (SAP) ; Sphingolipid-transfer protein ; Topology
; NCBI Molecular Biology Database ; SCOPUS
|
The record appears in these collections: |
